1. Madisch, Ahmed, et al. "Treatment of irritable bowel syndrome with herbal preparations: results of a double‐blind, randomized, placebo‐controlled, multi‐centre trial." Alimentary pharmacology & therapeutics 19.3 (2004): 271-279. Study funded by Steigerwald Arzneimittelwerk, GmbH
2. Von Arnim, Ulrike, et al. "STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study." The American journal of gastroenterology 102.6 (2007): 1268. Study funded by Steigerwald Arzneimittelwerk, GmbH
3. Ottillinger, Bertram, et al. "STW 5 (Iberogast®)—a safe and effective standard in the treatment of functional gastrointestinal disorders." Wiener Medizinische Wochenschrift 163.3-4 (2013): 65-72.
4. Abdel-Aziz, Heba, et al. "Evaluating the multitarget effects of combinations through multistep clustering of pharmacological data: the example of the commercial preparation iberogast." Planta medica 83.14/15 (2017): 1130-1140.
5. WHO Monographs on Medicinal Plants Commonly Used in the Newly Independent States (NIS). 2010. Accessed on 12 Feb 2019 at: http://apps.who.int/medicinedocs/en/m/abstract/Js17534en/
6. Mahboubi, Mohaddese. "Caraway as Important Medicinal Plants in Management of Diseases." Natural products and bioprospecting (2018): 1-11.
7. Wagner, H. "Multitarget therapy–the future of treatment for more than just functional dyspepsia." Phytomedicine 13 (2006): 122-129.
8. Gastroenterological Society of Australia and Digestive Health Foundation. Information about irritable bowel syndrome. Available from: http://cart.gesa.org.au/membes/files/Consumer Information/IBS.pdf Accessed Nov 2019
9. Irritable bowel syndrome diagnosis & management, The Gut Foundation. http://www.gutfoundation.com.au/publications-1/irritable-bowel-syndrome Accessed Nov 2019
10. Australian Psychological Society Stress and wellbeing in Australia survey 2015. Page 5 and 16